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ABSTRACT
BACKGROUND
Studies suggest that alcohol consumption and alcohol use disorders have distinct 
genetic backgrounds.
METHODS
We examined whether polygenic risk scores (PRS) for consumption and problem 
subscales of the Alcohol Use Disorders Identification Test (AUDIT-C, AUDIT-P) in the 
UK Biobank (UKB; N=121,630) correlate with alcohol outcomes in four independent 
samples: an ascertained cohort, the Collaborative Study on the Genetics of 
Alcoholism (COGA; N=6,850), and population-based cohorts: Avon Longitudinal 
Study of Parents and Children (ALSPAC; N=5,911), Generation Scotland (GS; 
N=17,461), and an independent subset of UKB (N=245,947). Regression models 
and survival analyses tested whether the PRS were associated with the alcohol-
related outcomes.
RESULTS                                              
In COGA, AUDIT-P PRS was associated with alcohol dependence, AUD symptom 
count, maximum drinks (R2=0.47% - 0.68%, p=2.0e-8 - 1.0e-10), and increased 
likelihood of onset of alcohol dependence (Hazard Ratio =1.15, p=4.7e-08); AUDIT-
C PRS was not an independent predictor of any phenotype. In ALSPAC, the AUDIT-C 
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PRS was associated with alcohol dependence (R2=0.96%, p=4.8e-6). In GS, AUDIT-
C PRS was a better predictor of weekly alcohol use (R2=0.27%, p=5.5e-11), while 
AUDIT-P PRS was more associated with problem drinking (R2=0.40%, p=9.0e-7). 
Lastly, AUDIT-P PRS was associated with ICD-based alcohol-related disorders in the 
UKB subset (R2=0.18%, p<2.0e-16).
CONCLUSIONS
AUDIT-P PRS was associated with a range of alcohol-related phenotypes across 
population-based and ascertained cohorts, while AUDIT-C PRS showed less utility in 
the ascertained cohort. We show that AUDIT-P is genetically correlated with both 
use and misuse and demonstrate the influence of ascertainment schemes on PRS 
analyses. 
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INTRODUCTION
Alcohol use, across the lifespan, can be characterized by a series of transitions: 
from early experimentation to hazardous drinking and possible development of 
alcohol use disorders (AUD), or to non-problematic alcohol intake. Some of these 
transitions are developmentally salient: for instance, hazardous drinking is common 
during adolescence and early adulthood, but does not always portend problematic 
use in later adulthood (Degenhardt et al., 2013; Wennberg, Andersson, & Bohman, 
2000). Similarly, individuals with AUD might remit, even to abstinence, or persist 
into later life (McCutcheon et al., 2012; Trim, Schuckit, & Smith, 2013). 
Furthermore, alcohol-related behavior can be broadly disarticulated into two 
components – the extent to which an individual consumes alcohol and the potential 
problems that they experience related to their intake. For instance, AUD are 
characterized not by excessive alcohol consumption but by measurable 
physiological changes that accompany addiction (e.g. withdrawal, tolerance) as well
as loss of control over drinking and drinking despite physical and emotional 
impairment (American Psychiatric Association, 2013). These complexities 
underlying the life course of alcohol use and misuse pose challenges in the 
dissection of etiology.
 
Most stages of alcohol involvement include a heritable contribution (twin h2 = 40-
70%), although the magnitude of these genetic effects varies considerably across 
development (Edwards et al., 2017; Enoch, 2006; Pagan et al., 2006). Common 
genetic variants from genome-wide association studies (GWAS) explain 4-13% of 
the phenotypic variance in alcohol use and misuse (Clarke et al., 2017; Kranzler et 
al., 2019; Liu et al., 2019; Sanchez-Roige et al., 2017; Schumann et al., 2016; 
4
Walters et al., 2018). The largest GWAS of alcohol dependence to date (Kranzler et 
al., 2019) suggests that the genetic correlation between alcohol consumption (units 
per week) and ICD coded AUD is variable (rg ranging from 0.54 (beer/cider) to 0.004 
(champagne/white wine)).
 
A recent study (Sanchez-Roige et al., 2018) conducted GWAS of both the 
consumption and problem subscales of the Alcohol Use Disorders Identification Test 
(AUDIT), a short screener for drinking in the past year (Saunders et al.,1993). In the
UK Biobank sample, genetic liability to the consumption subscale (AUDIT-C; three 
items with information pertaining to alcohol consumption) was positively correlated 
with educational achievement and unrelated to psychopathology whereas liability to
the problem subscale (AUDIT-P; seven items with information pertaining to alcohol 
problems) was negatively correlated with educational achievement and positively 
correlated with psychopathology. These findings are consistent with the lack of 
genetic correlation between psychiatric illness and genetic liability to alcohol 
consumption in the largest GWAS of the trait (drinks per week; Liu et al., 2019). In 
contrast, two recent studies suggest moderate genetic correlations between AUD 
and consumption indices, including the AUDIT-C (e.g., rg = 0.52, p = 2.40e-42) 
(Kranzler et al., 2019; Marees et al., 2019), while another study found that 
polygenic risk scores (PRS) for past week alcohol consumption predicted a modest 
but significant amount of variance in AUD (e.g., R2 = 0.56%; Johnson et al., 2019), 
suggesting that the genetic correspondence between recent consumption and 
dependence may be complicated by several factors, including the characteristics of 
the sample, and the nature of the assessment (e.g., alcohol quantity vs. frequency 
(Marees et al., 2019)).  
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In this study, we sought to examine the extent to which PRS derived from the 
AUDIT-C and AUDIT-P GWAS predicted variance in multiple aspects of alcohol use 
and misuse, ranging from levels of alcohol consumption, hazardous drinking, and 
AUD, in four independent samples that vary in their age and ascertainment scheme.
PRS are scores that represent an individual’s genetic liability for a certain trait or 
disorder, created by aggregating the effects of many risk variants for the phenotype
of interest, weighting the effect sizes by the number of effect alleles an individual 
carries at each locus. Prior evidence indicates that association between PRS and 
phenotype in the target sample is improved when both the discovery and target 
samples for PRS analyses are derived using similar ascertainment strategies 
(Savage et al., 2018). Based on a study showing positive correlations between 
psychopathology and AUDIT-P (but not AUDIT-C; Sanchez-Roige et al., 2018), we 
hypothesized that AUDIT-P PRS would be more closely related to liability to AUD 
than would AUDIT-C PRS, which would be more closely related to aspects of alcohol 
consumption (e.g., regular consumption, units per week). We also hypothesized that
associations with AUDIT-C would be stronger in the youngest sample while the 
AUDIT-P would be more predictive of drinking in older, ascertained samples in which
problem drinking is more established. While there have been some recent studies 
examining the genetic overlap between alcohol consumption and indices of problem
drinking (e.g., Johnson et al., 2019), none have yet compared the performance of 
consumption (AUDIT-C) versus problem drinking (AUDIT-P) PRS across multiple 
samples. Taken together, the current analyses demonstrate how genetic findings 
derived from a simple and fast screening tool could serve to outline the polygenic 
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underpinnings of different stages of alcohol use and problems in diversely 
ascertained samples.
 
MATERIALS AND METHODS
 
Discovery GWAS
The summary statistics of the recent GWAS of AUDIT-C and AUDIT-P in 121,604 
unrelated individuals of European ancestry from the UK Biobank cohort (Sanchez-
Roige et al., 2018) were used to construct PRS for alcohol-related outcomes in four 
independent target samples. The UK Biobank (UKB, www.ukbiobank.ac.uk) is a 
population-based sample of 502,629 participants who were recruited from 22 
assessment centers across the United Kingdom from 2006 to 2010 (Bycroft et al., 
2018); the AUDIT was delivered as part of the online Mental Health Questionnaire 
follow-up (Davis et al., 2018). Discovery GWAS analyses were performed using 
BGENIE (Bycroft et al., 2018), version 1.1, with AUDIT scores (AUDIT-C score, and 
AUDIT-P score, tested independently) as the outcome variable and age, sex, 
genotyping array, and the first 20 principal components derived from genotype data
as covariates to account for any remaining population stratification. Further details 
regarding the discovery GWAS are provided in the Supplemental Materials.
 
Target sample demographics and characteristics 
Collaborative Study on the Genetics of Alcoholism
The Collaborative Study on the Genetics of Alcoholism (COGA) (Begleiter et al., 
1995; Nurnberger et al., 2004; Schuckit et al., 2018) includes probands meeting 
criteria for alcohol dependence, their family members, and community control 
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families. There were 7,645 participants of European ancestry with genotype data 
available as well as data on alcohol-related phenotypes; of these, 6,850 were ≥20 
years (the mean age of onset of alcohol dependence) and reported lifetime alcohol 
use. 
 
Avon Longitudinal Study of Parents and Children
The Avon Longitudinal Study of Parents and Children (ALSPAC) recruited 14,541 
pregnant women residing in Avon, UK, with expected dates of delivery April 1, 1991,
to December 31, 1992. The enrolled sample consisted of 14,775 children. Additional
details are provided in the Supplemental Materials. For the current analyses, 
phenotypic data were available for up to 5,911 participants, depending on the 
phenotype and wave of assessment. Ethical approval for the study was obtained 
from the ALSPAC Ethics and Law Committee and the Local Research Ethics 
Committees.
 
Generation Scotland
The Scottish Family Health Study (GS) is a family-based cohort recruited from the 
general population of Scotland from 2006-2011 (N=24,084) (Smith et al., 2013). A 
subset of GS participants responded to a re-contact in 2015 (Navrady et al., 2018) 
and provided additional information on mental health, which included information 
on alcohol misuse (N = 17,461). 
 
UK Biobank
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Individuals who were part of the AUDIT discovery GWAS (Sanchez-Roige et al., 
2018) were removed from the UKB target sample, leaving 245,947 individuals with 
phenotypic data for these analyses. 
 
Alcohol use measures
A summary of the alcohol-related outcomes included in the analyses is presented in 
Table 1. Across all samples, participants who did not endorse lifetime alcohol use 
were removed to account for those with high genetic liability who elect not to drink 
for personal or socio-cultural reasons, or were not old enough to have had a first 
drink. Each target sample used a different assessment. Details regarding each 
assessment are available in the Supplementary Materials. Briefly, COGA 
participants were administered the Semi-Structured Interview for the Genetics of 
Alcoholism (SSAGA; (Bucholz et al., 1994)), which includes diagnostic assessments 
for DSM-IV and DSM-5 AUD as well as other aspects of alcohol use. ALSPAC 
participants completed the AUDIT questionnaire, and DSM-IV alcohol dependence 
was derived for 4,328 participants, using symptom-level items adapted from 
(Kendler, et al., 1992). In GS, participants reported on their alcohol intake (units per 
week) using a pre-clinical questionnaire, and were also administered the CAGE (Cut-
Annoyed-Guilty-Eye) screener (Ewing, 1984). In the UKB, ICD-9 and 10 codes for 
AUD were derived from linkage to hospital inpatient records. Phenotypic 
correlations between alcohol use measures across the samples are shown in 
Supplementary Table 16.
 
Genotypes
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Details on genotyping and quality control are shown in the Supplementary 
Materials. 
 
Polygenic risk score construction
For all samples, PRS were coded for every individual by multiplying an individual’s 
number of effect alleles at a particular SNP by that SNP’s effect size (beta) from the 
discovery GWAS (Sanchez-Roige et al., 2018) then averaging across SNPs to create 
one score per person. The discovery GWAS summary statistics were clumped using 
PLINK (Chang et al., 2015; Purcell et al., 2007) using the linkage disequilibrium (LD) 
pattern from the 1000 Genomes European (Consortium, 2015) reference sample, 
with an LD threshold of r2≥0.25 and a 500 kb physical distance. PRS were 
constructed for 8 thresholds (pT<0.0001, pT<0.001, pT<0.01, pT<0.10, pT<0.20, 
pT<0.30, pT<0.40, pT<0.50) and standardized using the scale function in R within 
each sample to ease interpretation of effect sizes. For ALSPAC and COGA, PRS were 
generated using PLINK; for UKB and GS samples, PRS were created using PLINK 
implemented in PRS-ice2 (Euesden et al., 2014) using the same R2 thresholds for 
clumping and the same p-value thresholds. 
 
Statistical Analyses
Linear and logistic regression models were used to examine whether AUDIT-C and 
AUDIT-P PRS were associated with each of the alcohol-related phenotypes (see 
Table 1), and to determine which PRS threshold (i.e., pT) was most predictive of 
each measure based on the p-value and observed (linear) or pseudo (logistic) R2. 
For the cohorts of unrelated individuals (ALSPAC and UKB), the partial R2 was 
extracted from linear regression models for continuous traits, while Nagelkerke’s 
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pseudo-R2 was extracted from logistic regression models for binary traits. For the 
cohorts that employed mixed-effect models to account for within-sample 
relatedness (COGA and GS), variance explained by the PRS in the continuous 
outcomes (e.g. MaxDrinks, CAGE) was calculated by multiplying the PRS by its 
regression coefficient and dividing the variance of that value by the variance of the 
outcome to derive a coefficient of determination between 0 and 1 (Nakagawa & 
Schielzeth, 2012); in COGA, the ‘MuMIn’ package in R was used to calculate 
marginal R2 for the logistic mixed-effect models for the binary outcomes (Barton, 
2011). Once the most predictive AUDIT-C and AUDIT-P PRS thresholds were 
determined in the single-PRS models (n.b. pT was allowed to vary between AUDIT-C 
and AUDIT-P PRS), the most predictive PRS for both AUDIT-C and AUDIT-P PRS were 
simultaneously entered into a joint regression model along with covariates (results 
for single-PRS models are in available in Supplemental Table 1-12). We primarily 
report on the results of the joint (AUDIT-C PRS + AUDIT-P PRS) regression models, 
as we wished to examine the relative contribution of each AUDIT subscale PRS while
controlling for the other subscale PRS. As the primary analyses consisted of 2 tests 
(AUDIT-C PRS and AUDIT-P PRS) for each of the 12 outcomes, and the number of 
independent tests across the PRS p-value thresholds was estimated to be 
approximately 5 (calculated using spectral decomposition, via the matSpD.R R 
script (Nyholt, 2004)), we corrected for 120 tests using a Bonferroni p-value = 
0.0004.   
 
COGA: Sex, 4 ancestral principal components (chosen via visual inspection of a 
scree plot of the eigenvalues), total number of interviews, birth cohort (born 1890-
1929, 1930-1949, 1950-1969, ≥1970), and array type (see Supplemental 
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Materials) were included as fixed effects, while the family identifier and 
recruitment site were included as random effects (family nested within site). 
 
ALSPAC  :  In keeping with standard practice for genetic analyses in ALSPAC, sex and 
10 ancestral principal components were included as covariates. ALSPAC 
assessments are age-specific, therefore age was not included as a covariate.  
GS: Analyses were performed in AS-REML-R fitting pedigree information as a 
random effect to control for relatedness in the sample. Fixed effects included age, 
sex and 4 multidimensional scaling components to correct for population 
stratification.  
UKB: Age, sex and 10 ancestry principal components were used as covariates. 
 
Cox proportional hazards survival models for onset of hazardous drinking (AUDIT 
total score ≥8) in ALSPAC and DSM-IV alcohol dependence in COGA were fit to the 
data with identical covariates as the regression analyses. Those who did not meet 
criteria for hazardous drinking or alcohol dependence were censored at their age at 
last interview (since age at birth). For ease of comparison across the two samples, 
the same PRS threshold (pT < 0.5) was used in both COGA and ALSPAC and for both 
the AUDIT-C and AUDIT-P PRS. Violations of the proportional hazards assumption for
the PRS were tested using scaled Schoenfeld residuals. All analyses were conducted
in R (R Core Team, 2017). In COGA, family identifier and recruitment site were 
included in the survival models as a nested frailty term (i.e. `(1 | site/family)`), 
using the “coxme” package for mixed-effect Cox proportional hazards models 
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containing Gaussian random effects (Therneau, 2018). ALSPAC data were analyzed 
using the “survival” and “survminer” packages in R (Kassambara et al., 2017; 
Therneau & Lumley, 2015)
For illustrative purposes, PRS were also split into quartiles for COGA, ALSPAC, and 
UKB, and the odds of having an AUD diagnosis (DSM-IV alcohol dependence in 
COGA and ALSPAC, ICD-9/ICD-10 alcohol related codes in UKB) was calculated in 
each quartile using the lowest quartile as the reference group. 
  
RESULTS
Target sample demographics and characteristics
The prevalence of each alcohol use measure for each target sample is shown in 
Table 1. The SNP-heritability of AUDIT-C was 11%, while the SNP-heritability of the 
AUDIT-P score was 9%, and the genetic correlation (i.e., SNP-rg) between them was 
rg = 0.70 (as reported in the original paper (Sanchez-Roige et al., 2018)). See 
Supplemental Table 15 for the number of SNPs in each PRS threshold.
 
COGA: 33.8% of the participants (N = 2,318) met DSM-IV criteria for alcohol 
dependence during their lifetime, with 77.6 % of those endorsing ≥6 (i.e., severe) 
DSM-5 AUD criteria. A median of 14.0 drinks (SD = 12.9; ~96 grams of alcohol, or 
14 standard US drinks) in a single 24-hour period was reported (i.e., MaxDrinks). 
90.0% of the participants reported drinking at least once a month for 6 consecutive 
months or longer (i.e., monthly alcohol use). 
ALSPAC: By age 23, 11.2% (N = 484) had met DSM-IV criteria for alcohol 
dependence within the past year at any of the three assessment waves, while 
13
66.2% reported hazardous drinking (AUDIT total score ≥8). The median MaxDrinks 
was 15 UK units (SD = 12.4; approximately 120 grams of alcohol, or 8.5 standard 
US drinks). 
GS: Mean alcohol intake was 10.9 units per week (SD = 12.8; approximately 87.2 
grams of alcohol, or 6.2 standard US drinks; N = 17,461) and the mean CAGE score 
was 0.6 (SD = 0.93).
UKB: There were 4,141 (1.68%) individuals in the subset of UKB selected for 
analysis who had at least one ICD-9 or ICD-10 code assigned as a primary or 
secondary diagnosis of alcohol related disorders during time as a hospital inpatient.
 
Associations between AUDIT PRS and consumption measures 
COGA: As shown in Table 2, only the AUDIT-P PRS was significantly associated with 
monthly alcohol use (R2= 0.65%, p = 1.24e-4) and MaxDrinks (R2= 0.47%, p = 
2.00e-8). We also converted the pseudo-R2 values for all binary outcomes to R2 on 
the liability scale (Lee et al., 2012), but as estimates did not differ, these results are 
not presented.
ALSPAC: AUDIT-C and AUDIT-P PRS accounted for increasing proportions of 
phenotypic variance in AUDIT-C and AUDIT-P scores as the sample aged, from 
~0.50% at age 16 to 1.12% at age 23 (see Supplementary Tables 8-9 for 
complete results). Here we focus on results for age 23 for comparability to other 
samples, which consisted predominantly of adults. No association survived the 
correction for multiple tests. The strongest associations observed were for AUDIT-C 
and AUDIT-P PRS, which were both associated with higher AUDIT-C scores in ALSPAC
at age 23, each explaining 0.60% of the variance (p = 1.06e-3 and 5.9e-4, 
14
respectively), and between AUDIT-P PRS and MaxDrinks (R2= 3.30%, p = 1.59e-3); a
1-SD increase in AUDIT-P PRS corresponds to a predicted increase of 0.54 drinks.
GS: The AUDIT-P PRS explained 0.15% of the variance in units per week (p = 4.7e-7)
and 0.40% of the variance in CAGE scores (p = 9.0e-7), while the AUDIT-C PRS 
explained 0.27% of the variance in units per week (p = 5.5e-11).
 
Associations between AUDIT PRS and alcohol problem measures
COGA: As shown in Table 2, only the AUDIT-P PRS was significantly associated with 
DSM-IV alcohol dependence (R2 = 0.68%, p = 4.55e-9) and DSM-5 AUD symptom 
count (R2 = 0.67%, p = 1.01e-10). For individuals in the top quartile of AUDIT-P PRS 
risk, the odds of being diagnosed with alcohol dependence was 1.74 (95% 
confidence intervals (C.I.) = 1.47-2.07) compared to those in the lowest quartile, 
while being in the top AUDIT-C PRS quartile was associated with an odds ratio (OR) 
of 1.30 (95% C.I. = 1.10 -1.54) compared to those in the lowest quartile (Figure 1). 
Comparison of the OR and their 95% C.I. suggest that for AUDIT-C, those in the 4th 
quartile are at significantly elevated likelihood of AUD compared to those in lowest 
quartile, though there were overlapping 95% C.I. between the 2nd, 3rd, and 4th 
quartiles. In contrast, for AUDIT-P, likelihood of AUD escalates at the mid-point, with 
those in the both the 3rd and 4th quartiles being at significantly greater risk of AUD 
than those in the lowest quartile of AUDIT-P PRS.
ALSPAC: Only AUDIT-P PRS were associated with AUDIT-P scores, accounting for 
1.1% of the variance (p = 9.05e-6). AUDIT-C PRS and AUDIT-P PRS were both 
positively associated with DSM-IV alcohol dependence, explaining 1.0% (p = 4.81e-
6) and 0.50% (p = 5.75e-4) of the variance, respectively, although only the AUDIT-C
PRS passed multiple testing corrections. Both PRS scores were also positively 
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associated with DSM-IV alcohol dependence symptom count (R2 = 0.8% for both; 
AUDIT-C p = 3.59e-5, AUDIT-P p = 3.53e-5). For individuals in the top quartile of 
AUDIT-C PRS, the odds of being diagnosed with AUD was 1.73 (95% C.I. = 1.29-
2.33) compared to those in the lowest quartile, while being in the top AUDIT-P PRS 
quartile was associated with an OR of 1.25 (95% C.I. = 0.93 -1.68) compared to 
those in the lowest quartile (Figure 1). Due to wider 95% C.I. (suggesting 
imprecision potentially due to smaller sample size and/or less of a dose-response 
association pattern), it was difficult to draw comparisons of the ORs across quartiles
in the ALSPAC sample. For AUDIT-C, differentiation in likelihood of AUD appeared to 
occur at the 3rd quartile, while for AUDIT-P, there was no clear distinction in the OR 
across the 2nd, 3rd and 4th quartiles.
UKB: Positive associations with AUD-related ICD codes were observed for both 
AUDIT-P (R2 = 0.18%, p < 2e-16) and AUDIT-C (R2 = 0.04%, p = 8.9e-5) PRS. For 
individuals in the top quartile of AUDIT-P PRS, the odds of having a mental or 
behavioral disorder due to alcohol was 1.45 (95% C.I. = 1.37-1.54) compared to 
those in the lowest quartile. For AUDIT-C PRS, being in the top PRS quartile was 
associated with an odds-ratio of 1.11 (95% C.I. = 1.02-1.20) compared to those in 
the lowest quartile (Figure 1).  In the UKB, likelihood of AUD across quartiles 
seemed to follow a dose-response pattern with increasing OR for each quartile of 
polygenic risk for both AUDIT-C and AUDIT-P (though with overlapping C.I. for 
AUDIT-C), with the 4th quartile of AUDIT-P PRS being statistically significantly more 
likely to be diagnosed with AUD relative to the 3rd quartile.
 
Associations between AUDIT PRS and onset of hazardous drinking and 
alcohol dependence
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COGA: The AUDIT-P, but not the AUDIT-C, PRS was associated with increased 
hazards of alcohol dependence onset (AUDIT-P HR = 1.15, 95% CI = 1.10-1.20, p = 
4.7e-08; Supplemental Table 13). Those in the top quartile of AUDIT-P PRS were 
at considerably higher risk for onset of alcohol dependence (HR = 1.50, 95% CI = 
1.36-1.64, p = 9.7e-10) relative to any other group; the risk attributable to the top 
AUDIT-C PRS was lower in magnitude (HR = 1.27, 95% CI = 1.14-1.40, p = 1.8e-4). 
ALSPAC: Only the AUDIT-C PRS was associated with onset of hazardous drinking, 
although not significant after multiple testing corrections (Supplemental Table 
14; AUDIT-C HR = 1.06, 95% CI = 1.02-1.10, p = 2.28e-3).
 
DISCUSSION
The course of alcohol use and misuse consists of several stages, each with 
polygenic and environmental underpinnings. At earlier ages, how much and how 
often a person drinks often serves as an indicator of their genetic susceptibility to 
alcohol misuse (Dick et al., 2011; Irons et al., 2015). As an individual progresses 
towards maladaptive alcohol intake, a unique genetic susceptibility to physiological 
and psychological impairments related to alcohol misuse may unfold (Kendler et al.,
2011). Our goal was to outline the extent to which PRS derived from a discovery 
GWAS of the AUDIT consumption (AUDIT-C) and problem (AUDIT-P) subscales 
predicted variance in a range of alcohol use behaviors across samples that were 
variously ascertained. With few exceptions, polygenic liability to AUDIT-P was a 
superior predictor of indices of heavy drinking and alcohol problems compared to 
the AUDIT-C. 
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Overall, across several ascertainment strategies, AUDIT-P PRS outperformed AUDIT-
C as a predictor of both normative and disordered drinking (see Figure 2 for an 
overview). For example, AUDIT-P PRS predicted up to 3.3% of the variance in the 
lifetime maximum number of drinks consumed in a 24-hour period (although this 
was a clear outlier in terms of variance explained), 1.1% of the variance in AUDIT-P 
scores, and 0.7% of the variance in DSM-5 AUD symptom counts. Exceptions to the 
superior performance of AUDIT-P PRS were observed within ALSPAC, where AUDIT-C
PRS explained higher proportions of variance than AUDIT-P PRS in some adolescent 
AUDIT-C and AUDIT-P assessments (prior to age 23; see Supplemental Materials).
AUDIT-C PRS also accounted for more variance in DSM-IV AD in ALSPAC.
Even indices of alcohol consumption, such as lifetime maximum drinks in 24 hours 
and monthly alcohol use, were more closely related to the genetic liability indexed 
by AUDIT-P PRS than AUDIT-C PRS. However, this difference was most notable in 
COGA, for which drinking for at least 6 months during the lifetime represents a 
highly heterogeneous group of individuals, which may include both non-problem 
drinkers and those with AUD. As expected, and in line with prior studies (Mies et al., 
2018; Sanchez-Roige et al., 2018), AUDIT-P outperformed AUDIT-C for measures of 
problem drinking within each sample (i.e., COGA, ALSPAC, GS and UKB; see Table 
2), confirming that the AUDIT-P is more closely related to genetic susceptibility to 
alcohol misuse than AUDIT-C. 
Overall, the variance explained by PRS was low, even when the discovery and 
target phenotypes were identical (e.g. AUDIT scores in ALSPAC). These estimates 
are nonetheless consistent with other PRS studies (Mies et al., 2018; Savage et al., 
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2018), and the proportion of explained variance may improve as the discovery 
GWAS get larger. In agreement with previous studies (Savage et al., 2018), we 
demonstrated that ascertainment is likely to be a crucial factor in polygenic 
prediction analyses. For instance, while the AUDIT-P PRS explained a larger amount 
of variance in dependence in COGA than in ALSPAC, the AUDIT-C PRS was not a 
significant predictor for any phenotype in COGA over and above the effect of AUDIT-
P PRS, suggesting that the effect sizes for AUDIT-C from a volunteer cohort (UKB) 
may not be optimal for capturing genetic risk to AUD in high-risk families, such as 
those in COGA. AUDIT-C associations in COGA using other addiction-enriched 
samples, such as the Million Veteran Program (Kranzler et al., 2019), where the 
genetic correlation between AUDIT-C and AUD is high, will likely provide insights 
into the extent of the effect of ascertainment differences in discovery and target 
samples. Interestingly, variance explained by either PRS was the highest in ALSPAC,
a population-based cohort that is noticeably younger than the discovery sample 
(age 39-79 years). Lastly, the variance explained for AUD in the (independent) 
subset of UKB participants itself was markedly lower than in ALSPAC. Here, it is 
worth recognizing that AUDIT is a past-year screener for alcohol 
consumption/problems, and there may have been individuals in the original AUDIT 
GWAS with low scores who were formerly problem drinkers. Furthermore, using ICD 
codes derived from hospital records as a proxy for AUD in the UKB may have 
resulted in false negatives; some of the 'controls' could have been problem drinkers
but had not been  diagnosed with an alcohol related condition as a hospital 
inpatient. Thus, the lower prediction in the UKB sample may reflect the instruments 
used to measure AUD in both the discovery and target GWAS. 
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Our findings should be viewed in the context of several limitations. First, the AUDIT 
is a past-year screener for alcohol consumption and problems, and thus may not 
capture individuals who had alcohol use problems in the past. Second, the AUDIT 
discovery GWAS was performed in a subset of the UKB that consisted of individuals 
who responded to an email request to complete a mental health follow-up survey. A
recent study of the genomic profiles of these individuals has found them to 
represent lower polygenic risk for psychopathology and greater polygenic load for 
educational achievement, suggesting selection bias in the discovery sample itself 
(Adams et al., 2018). In addition, these individuals had relatively low endorsement 
of AUDIT-P items, which might have limited the statistical power of the discovery 
GWAS to capture the full spectrum of problem drinking and, in turn, limited our 
ability to compare across the AUDIT-C and AUDIT-P.  Third, as the discovery GWAS 
was conducted on individuals of primarily European descent, these PRS could not be
applied to other ancestral groups, reflecting a research gap in the dearth of large 
discovery GWAS of non-European populations (Martin et al., 2017). Results from the
recent AUDIT-C GWAS by Kranzler et al (2019), which includes 57,340 African-
Americans, for instance, will be instrumental in bridging this gap. Fourth, it is likely 
that the pattern of results reflects a complex interplay between developmental 
effects, ascertainment strategy, the psychometrics of the assessment instruments, 
and even population selection effects. For instance, distinctions between ALSPAC 
and COGA could be attributed to the higher median age of COGA participants, or 
even drinking patterns prevalent in earlier birth cohorts that are represented within 
COGA. Potential moderation of PRS by sex are also possible; however, power for 
such exploratory analyses is limited and beyond the scope of this study. Fifth, 
although this study examined a range of alcohol use phenotypes (from a measure of
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monthly alcohol use to dependence), the cross-sectional design cannot capture 
potential longitudinal changes in PRS association across the progression of stages of
alcohol use. A sixth limitation is that we did not control for any measures of 
socioeconomic status (SES) in our models, although SES has been shown to be a 
potential moderator of polygenic risk for alcohol consumption (Clarke et al., 2016; 
Barr et al., 2018), as the measures available varied widely and inconsistently across
our target samples. The imbalance of cases and controls in the UK Biobank target 
sample is another limitation; this imbalance would be more likely to seriously bias a 
discovery GWAS, but may still have confounded the regression analyses in our 
target sample. A final limitation is that the strength of PRS associations varied 
across p-value thresholds (pT; see Supplementary Tables 1-12); because we 
chose the best-performing pT for each model, as is typical for the 
pruning+thresholding (P+T) method of polygenic risk score analyses (Euesden et 
al., 2014), we run the risk of over-fitting.  
Collectively, these analyses demonstrate that much of the polygenic liability to 
alcohol use and misuse remains unaccounted for – we anticipate that much larger 
GWAS of phenotypes representing disordered drinking, in conjunction with other 
risk indices (e.g., PRS for negative affect, a hallmark of later stages of AUD) will be 
necessary to explain additional variance. Importantly, as the use of PRS becomes 
increasingly common in attempts to dissect the transitions from experimentation, to
regular or problem use and further, to AUD, differences between the discovery 
sample and target sample(s) in age, ascertainment, and other characteristics will 
need to be considered in the interpretation of findings. In addition, our findings 
highlight the high degree of heterogeneity and polygenicity underlying alcohol use 
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and misuse – not only is there no “gene for” alcoholism, there is currently no robust 
“polygenic indicator for” clinical prediction of liability to problem drinking. 
Furthermore, while we focused on contrasting the genetic relationship of each 
individual AUDIT subscale with the variety of alcohol-related measures across our 
different samples, it should be noted that the proportion of variance explained in 
the alcohol-related outcomes is larger when we consider both the AUDIT-C and 
AUDIT-P PRS together, suggesting that multiple polygenic scores provide more 
utility than PRS for the individual sub-scales. The two scores are only modestly 
correlated and likely, some of this commonality is due to variants in ADH1B that 
exert a relatively large effect. Overall, our analyses suggest that even though it is 
far too small to be statistically significant, there is some incremental contribution of 
variance from inclusion of the AUDIT-C. Despite these caveats, our analyses 
demonstrate the feasibility of using a fast and simple screening questionnaire, the 
AUDIT, that assesses both consumption and problem drinking, to understand the 
course of alcohol use and misuse.
 
 FINANCIAL DISCLOSURES
Dr. McIntosh has received research support from Eli Lilly, Janssen, Pfizer, and the 
Sackler Foundation. The remaining authors report no potential conflicts of interest 
to disclose.
ACKNOWLEDGEMENTS 
 
This research was conducted using the UK Biobank Resource, application number 
4844. 
22
ECJ was supported by funding from NIAAA (1F32AA027435). S.S-R was supported by
the Frontiers of Innovation Scholars Program (FISP; #3-P3029), the Interdisciplinary 
Research Fellowship in NeuroAIDS (IRFN; MH081482), a pilot award from the NIH 
(DA037844) and a NARSAD Young Investigator Award from the Brain and Behavior 
Foundation (Grant Number 27676). SSR and AAP were supported by funds from the 
California Tobacco-Related Disease Research Program (TRDRP; Grant Number 28IR-
0070 and T29KT0526). AA receives support from K02DA032573. VH receives 
support from P60AA03510. DMD acknowledges support from K02AA018755. JLM is 
supported by K01DA037914.
 
ALSPAC: We are extremely grateful to all the families who took part in this study, 
the midwives for their help in recruiting them, and the whole ALSPAC team, which 
includes interviewers, computer and laboratory technicians, clerical workers, 
research scientists, volunteers, managers, receptionists and nurses.
The UK Medical Research Council and Wellcome (Grant ref: 102215/2/13/2) and the 
University
of Bristol provide core support for ALSPAC. This publication is the work of the 
authors and
EMC, ACE, and AA will serve as guarantors for the contents of this paper. A 
comprehensive list of grants funding is available on the ALSPAC website
(http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). 
This research was specifically funded by NIH grants AA021399, AA018333, and 
AA022537. ACE was further supported by a Young Investigator award from the Brain
and Behavior Foundation (Grant Number 24864). GWAS data were generated by 
23
Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and 
LabCorp (Laboratory Corporation of America) using support from 23andMe.
 
COGA: The Collaborative Study on the Genetics of Alcoholism (COGA), Principal 
Investigators B. Porjesz, V. Hesselbrock, H. Edenberg, L. Bierut, includes eleven 
different centers: University of Connecticut (V. Hesselbrock); Indiana University (H.J.
Edenberg, J. Nurnberger Jr., T. Foroud; Y. Liu); University of Iowa (S. Kuperman, J. 
Kramer); SUNY Downstate (B. Porjesz); Washington University in St. Louis (L. Bierut, 
J. Rice, K. Bucholz, A. Agrawal); University of California at San Diego (M. Schuckit); 
Rutgers University (J. Tischfield, A. Brooks); Department of Biomedical and Health 
Informatics, The Children’s Hospital of Philadelphia; Department of Genetics, 
Perelman School of Medicine, University of Pennsylvania, Philadelphia PA (L. 
Almasy), Virginia Commonwealth University (D. Dick), Icahn School of Medicine at 
Mount Sinai (A. Goate), and Howard University (R. Taylor). Other COGA collaborators
include: L. Bauer (University of Connecticut); J. McClintick, L. Wetherill, X. Xuei, D. 
Lai, S. O’Connor, M. H. Plawecki, S. Lourens (Indiana University); G. Chan (University
of Iowa; University of Connecticut); J. Meyers, D. Chorlian, C. Kamarajan, A. Pandey, 
J. Zhang (SUNY Downstate); J.-C. Wang, M. Kapoor, S. Bertelsen (Icahn School of 
Medicine at Mount Sinai); A. Anokhin, V. McCutcheon, S. Saccone (Washington 
University); J. Salvatore, F. Aliev, B. Cho (Virginia Commonwealth University); and 
Mark Kos (University of Texas Rio Grande Valley). A. Parsian and H. Chen are the 
NIAAA Staff Collaborators.
24
We continue to be inspired by our memories of Henri Begleiter and Theodore Reich, 
founding PI and Co-PI of COGA, and also owe a debt of gratitude to other past 
organizers of COGA, including Ting-Kai Li, P. Michael Conneally, Raymond Crowe, 
and Wendy Reich, for their critical contributions. This national collaborative study is 
supported by NIH Grant U10AA008401 from the National Institute on Alcohol Abuse 
and Alcoholism (NIAAA) and the National Institute on Drug Abuse (NIDA).
Generation Scotland: Generation Scotland received core support from the Chief 
Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the 
Scottish Funding Council [HR03006]. Genotyping of the GS:SFHS samples was 
carried out by the Genetics Core Laboratory at the Wellcome Trust Clinical Research
Facility, Edinburgh, Scotland and was funded by the Medical Research Council UK 
and the Wellcome Trust (Wellcome Trust Strategic Award “STratifying Resilience 
and Depression Longitudinally” (STRADL) Reference 104036/Z/14/Z). AMM received 
support from an MRC Mental Health Data Pathfinder Grant (reference 
MC_PC_17209). 
25
REFERENCES
Adams, M., Hill, W. D., Howard, D. M., Davis, K. A. S., Deary, I. J., Hotopf, M., & 
McIntosh, A. M. (2018). Factors associated with sharing email information and 
mental health survey participation in two large population cohorts. BioRxiv, 
471433. https://doi.org/10.1101/471433
American Psychiatric Association. (2013). Diagnostic and statistical manual of 
mental disorders (DSM-5®). American Psychiatric Pub.
Barr, P. B. et al. (2018) ‘Childhood socioeconomic status and longitudinal patterns of
alcohol problems: Variation across etiological pathways in genetic risk’, Social 
Science & Medicine. Elsevier, 209, pp. 51–58.
Barton, K. (2011). MuMIn: multi-model inference. R package v. 1.6. 5.
Begleiter, H., Reich, T., Hesselbrock, V., Porjesz, B., Li, T.-K., Schuckit, M. A., … Rice, 
J. P. (1995). The collaborative study on the genetics of alcoholism. Alcohol 
Health and Research World, 19, 228.
Berg, J. J., Harpak, A., Sinnott-Armstrong, N., Joergensen, A. M., Mostafavi, H., Field, 
Y., … Coop, G. (2018). Reduced signal for polygenic adaptation of height in UK 
Biobank. BioRxiv, 354951. https://doi.org/10.1101/354951
Bucholz, K. K., Cadoret, R., Cloninger, C. R., Dinwiddie, S. H., Hesselbrock, V. M., 
Nurnberger, J. I., … Schuckit, M. A. (1994). A new, semi-structured psychiatric 
interview for use in genetic linkage studies: a report on the reliability of the 
SSAGA. Journal of Studies on Alcohol, 55(2), 149–158. 
https://doi.org/10.15288/jsa.1994.55.149
Bucholz, K. K., McCutcheon, V. V., Agrawal, A., Dick, D. M., Hesselbrock, V. M., 
Kramer, J. R., … Porjesz, B. (2017). Comparison of Parent, Peer, Psychiatric, and 
Cannabis Use Influences Across Stages of Offspring Alcohol Involvement: 
Evidence from the COGA Prospective Study. Alcoholism: Clinical and 
Experimental Research, 41(2), 359–368. https://doi.org/10.1111/acer.13293
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., … Marchini, J. 
(2018). The UK Biobank resource with deep phenotyping and genomic data. 
Nature, 562(7726), 203–209. https://doi.org/10.1038/s41586-018-0579-z
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015).
Second-generation PLINK: rising to the challenge of larger and richer datasets. 
GigaScience, 4(1), 7. https://doi.org/10.1186/s13742-015-0047-8
Clarke, T. et al. (2016) ‘Polygenic risk for alcohol dependence associates with 
alcohol consumption, cognitive function and social deprivation in a population‐
based cohort’, Addiction biology. Wiley Online Library, 21(2), pp. 469–480.
Clarke, T.-K., Adams, M. J., Davies, G., Howard, D. M., Hall, L. S., Padmanabhan, S., 
… McIntosh, A. M. (2017, July). Genome-wide association study of alcohol 
consumption and genetic overlap with other health-related traits in UK Biobank 
(N=112,117). Molecular Psychiatry. The Author(s). 
https://doi.org/10.1038/mp.2017.153
Consortium, T. 1000 G. P. (2015). A global reference for human genetic variation. 
Nature, 526(7571), 68–74.
Davis, K. A. S. et al. (2018) ‘Mental health in UK Biobank: development, 
implementation and results from an online questionnaire completed by 157 366 
participants’, BJPsych open. Cambridge University Press, 4(3), pp. 83–90.
Degenhardt, L., O’Loughlin, C., Swift, W., Romaniuk, H., Carlin, J., Coffey, C., … 
Patton, G. (2013). The persistence of adolescent binge drinking into adulthood: 
findings from a 15-year prospective cohort study. BMJ Open, 3(8), e003015.
26
Dick, D. M., Meyers, J. L., Rose, R. J., Kaprio, J., & Kendler, K. S. (2011). Measures of 
current alcohol consumption and problems: two independent twin studies 
suggest a complex genetic architecture. Alcoholism: Clinical and Experimental 
Research, 35(12), 2152–2161.
Edwards, A. C., Heron, J., Vladimirov, V., Wolen, A. R., Adkins, D. E., Aliev, F., … 
Kendler, K. S. (2017). The Rate of Change in Alcohol Misuse Across Adolescence
is Heritable. Alcoholism: Clinical and Experimental Research, 41(1), 57–64. 
https://doi.org/10.1111/acer.13262
ENOCH, M.-A. (2006). Genetic and Environmental Influences on the Development of 
Alcoholism. Annals of the New York Academy of Sciences, 1094(1), 193–201. 
https://doi.org/10.1196/annals.1376.019
Euesden, J., Lewis, C. M., & O’reilly, P. F. (2014). PRSice: polygenic risk score 
software. Bioinformatics, 31(9), 1466–1468.
Ewing, J. A. (1984). Detecting Alcoholism: The CAGE Questionnaire. JAMA: The 
Journal of the American Medical Association, 25(14), 1905–1907. https://doi.org/
10.1001/jama.1984.03350140051025
Irons, D. E., Iacono, W. G., & McGue, M. (2015). Tests of the effects of adolescent 
early alcohol exposures on adult outcomes. Addiction (Abingdon, England), 
110(2), 269–278. https://doi.org/10.1111/add.12747
Johnson, E. C., St.Pierre, C. L., Meyers, J. , Aliev, F. , McCutcheon, V. V., Lai, D. , Dick,
D. M., Goate, A. M., Kramer, J. , Kuperman, S. , Nurnberger, J. I., Schuckit, M. A., 
Porjesz, B. , Edenberg, H. J., Bucholz, K. K. and Agrawal, A. (2019), The genetic 
relationship between alcohol consumption and aspects of problem drinking in 
an ascertained sample. Alcohol Clin Exp Re. Accepted Author Manuscript. 
doi:10.1111/acer.14064
Kassambara, A., Kosinski, M., & Biecek, P. (2017). survminer: Drawing Survival 
Curves using’ggplot2’. R Package Version 0.3, 1.
Kendler, K. S., Gardner, C., & Dick, D. M. (2011). Predicting alcohol consumption in 
adolescence from alcohol-specific and general externalizing genetic risk factors,
key environmental exposures and their interaction. Psychological Medicine, 
41(7), 1507–1516. https://doi.org/10.1017/S003329171000190X
Kendler, K. S., Heath, A. C., Neale, M. C., Kessler, R. C., & Eaves, L. J. (1992). A 
Population-Based Twin Study of Alcoholism in Women. JAMA, 268(14), 1877–
1882. https://doi.org/10.1001/jama.1992.03490140085040
Kranzler, H. R., Zhou, H., Kember, R. L., Smith, R. V., Justice, A. C., Damrauer, S., ... 
& Gelernter, J. (2019). Genome-wide association study of alcohol consumption 
and use disorder in 274,424 individuals from multiple populations. Nature 
communications, 10(1), 1499.
Lee, S. H. et al. (2012) ‘A Better Coefficient of Determination for Genetic Profile 
Analysis’, Genetic Epidemiology. John Wiley & Sons, Ltd, 36(3), pp. 214–224. doi: 
10.1002/gepi.21614.
Liu, M., Jiang, Y., Wedow, R., Li, Y., Brazel, D. M., Chen, F., … Psychiatry, H. A.-I. 
(2019). Association studies of up to 1.2 million individuals yield new insights 
into the genetic etiology of tobacco and alcohol use. Nature Genetics, 51(2), 
237–244. https://doi.org/10.1038/s41588-018-0307-5
Marees, A., Smit, D., Ong, J., MacGregor, S., An, J., Denys, D., . . . Derks, E. (n.d.). 
Potential influence of socioeconomic status on genetic correlations between 
alcohol consumption measures and mental health. Psychological Medicine, 1-
15. doi:10.1017/S0033291719000357
Martin, A. R., Gignoux, C. R., Walters, R. K., Wojcik, G. L., Neale, B. M., Gravel, S., … 
27
Kenny, E. E. (2017). Human demographic history impacts genetic risk prediction
across diverse populations. The American Journal of Human Genetics, 100(4), 
635–649.
McCutcheon, V. V, Grant, J. D., Heath, A. C., Bucholz, K. K., Sartor, C. E., Nelson, E. 
C., … Martin, N. G. (2012). Environmental influences predominate in remission 
from alcohol use disorder in young adult twins. Psychological Medicine, 42(11), 
2421–2431.
Mies, G. W., Verweij, K. J. H., Treur, J. L., Ligthart, L., Fedko, I. O., Hottenga, J. J., … 
Vink, J. M. (2018). Polygenic risk for alcohol consumption and its association 
with alcohol-related phenotypes: Do stress and life satisfaction moderate these 
relationships? Drug and Alcohol Dependence, 183, 7–12.
Nakagawa, S., & Schielzeth, H. (2012). A general and simple method for obtaining 
R2 from generalized linear mixed-effects models. Methods in Ecology and 
Evolution, 4(2), 133–142. https://doi.org/10.1111/j.2041-210x.2012.00261.x
Navrady, L. B., Wolters, M. K., MacIntyre, D. J., Clarke, T. K., Campbell, A. I., Murray, 
A. D., … McIntosh, A. M. (2018). Cohort profile: Stratifying Resilience and 
Depression Longitudinally (STRADL): A questionnaire follow-up of Generation 
Scotland: Scottish Family Health Study (GS: SFHS). International Journal of 
Epidemiology, 47(1), 13–14g. https://doi.org/10.1093/ije/dyx115
Nurnberger, J. I., Wiegand, R., Bucholz, K., O’Connor, S., Meyer, E. T., Reich, T., ... & 
Bierut, L. (2004). A family study of alcohol dependence: coaggregation of 
multiple disorders in relatives of alcohol-dependent probands. Archives of 
general psychiatry, 61(12), 1246-1256.
Nyholt, D. R. (2004) ‘A simple correction for multiple testing for single-nucleotide 
polymorphisms in linkage disequilibrium with each other’, The American Journal of 
Human Genetics. Elsevier, 74(4), pp. 765–769.
Pagan, J. L., Rose, R. J., Viken, R. J., Pulkkinen, L., Kaprio, J., & Dick, D. M. (2006). 
Genetic and environmental influences on stages of alcohol use across 
adolescence and into young adulthood. Behavior Genetics, 36(4), 483–497. 
https://doi.org/10.1007/s10519-006-9062-y
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., … 
Sham, P. C. (2007). PLINK: A Tool Set for Whole-Genome Association and 
Population-Based Linkage Analyses. The American Journal of Human Genetics. 
https://doi.org/10.1086/519795
R Core Team. (2017). R: A language and environment for statistical computing. 
Vienna, Austria: R Foundation for Statistical Computing.
Sanchez-Roige, S., Fontanillas, P., Elson, S. L., Gray, J. C., de Wit, H., Davis, L. K., …  
Palmer, A. A. (2017). Genome-wide association study of alcohol use disorder 
identification test (AUDIT) scores in 20 328 research participants of European 
ancestry. Addiction Biology. https://doi.org/10.1111/adb.12574
Sanchez-Roige, S., Palmer, A. A., Fontanillas, P., Elson, S. L., 23andMe Research 
Team, Substance Use Disorder Working Group of the Psychiatric Genomics 
Consortium, … Clarke, T.-K. (2018). Genome-Wide Association Study Meta-
Analysis of the Alcohol Use Disorders Identification Test (AUDIT) in Two 
Population-Based Cohorts. American Journal of Psychiatry. 
https://doi.org/https://doi.org/10.1176/appi.ajp.2018.18040369
Saunders, J. B., Aasland, O. G., Babor, T. F., De la Fuente, J. R., & Grant, M. (1993). 
Development of the alcohol use disorders identification test (AUDIT): WHO 
collaborative project on early detection of persons with harmful alcohol 
28
consumption‐II. Addiction, 88(6), 791–804.
Savage, J. E., Salvatore, J. E., Aliev, F., Edwards, A. C., Hickman, M., Kendler, K. S., …
Kaprio, J. (2018). Polygenic Risk Score Prediction of Alcohol Dependence 
Symptoms Across Population‐Based and Clinically Ascertained Samples. 
Alcoholism: Clinical and Experimental Research, 42(3), 520–530.
Schuckit, M. A., Smith, T. L., Danko, G., Kramer, J., Bucholz, K. K., McCutcheon, V., ...
& Hesselbrock, M. (2018). A 22‐Year Follow‐Up (Range 16 to 23) of Original 
Subjects with Baseline Alcohol Use Disorders from the Collaborative Study on 
Genetics of Alcoholism. Alcoholism: Clinical and Experimental Research, 42(9), 
1704-1714.
Schumann, G., Liu, C., O’Reilly, P., Gao, H., Song, P., Xu, B., … Elliott, P. (2016). KLB 
is associated with alcohol drinking, and its gene product β-Klotho is necessary 
for FGF21 regulation of alcohol preference. Proc Natl Acad Sci USA, 113(50), 
14372–14377.
Smith, B. H., Campbell, A., Linksted, P., Fitzpatrick, B., Jackson, C., Kerr, S. M., … 
Morris, A. D. (2013). Cohort Profile: Generation Scotland: Scottish Family Health
Study (GS:SFHS). The study, its participants and their potential for genetic 
research on health and illness. International Journal of Epidemiology. 
https://doi.org/10.1093/ije/dys084
Therneau, T. M. (2018). Package ‘coxme.’ Mixed Effects Cox Models. R Package 
Version, 2.
Therneau, T. M., & Grambsch, P. M. (2013). Modeling survival data: extending the 
Cox model. Springer Science & Business Media.
Therneau, T. M., & Lumley, T. (2015). Package ‘survival.’ R Top Doc, 128.
Trim, R. S., Schuckit, M. A., & Smith, T. L. (2013). Predictors of Initial and Sustained 
Remission from Alcohol Use Disorders: Findings from the 30‐Year Follow‐Up of 
the S an D iego Prospective Study. Alcoholism: Clinical and Experimental 
Research, 37(8), 1424–1431.
Walters, R. K., Polimanti, R., Johnson, E. C., McClintick, J. N., Adams, M. J., Adkins, A. 
E., … Team, 23andMe Research. (2018). Transancestral GWAS of alcohol 
dependence reveals common genetic underpinnings with psychiatric disorders. 
Nature Neuroscience, 21(12), 1656–1669. https://doi.org/10.1038/s41593-018-
0275-1
Wennberg, P., Andersson, T., & Bohman, M. (2000). Associations between different 
aspects of alcohol habits in adolescence, early adulthood, and early middle age:
a prospective longitudinal study of a representative cohort of men and women. 
Psychology of Addictive Behaviors, 14(3), 303.
29
TABLES
Table 1. Alcohol-related measures in each target sample. C, Continuous (linear regression model
used); B, Binary (logistic regression model used)
Drinking measure Definitions
Trait
Continuou
s/
Binary
COGA 
Ascertained for
AUD
ALSPAC
Population-based
GS
Populatio
n-based
UKB
Population
-based
Units per
week (Mean,
SD)
C n/a n/a 10.9(12.8) n/a
Alcohol use
(N, %) B
Ever drank once a
month for 6
consecutive months
or longer
6,163 (90.0%)
n/a n/a n/a
Maxdrinks
(Median, SD) C
Lifetime maximum
drinks consumed in
a single 24-hour
period
14.0 (12.87)
Lifetime maximum
drinks consumed in a
single 24-hour period
15.0 (12.35)
n/a n/a
Hazardous
drinking (N,
%)
B n/a
AUDIT total score
cutoff of 8+ at any
age
3264 (66.2%)
n/a n/a
AUDIT-C score
(Mean, SD) C n/a
Sum of AUDIT items
1-3
Age 16 4.80 (2.59)
Age 18 5.04 (2.26)
Age 19 6.01 (2.50)
n/a n/a
30
Age 21 6.11 (2.43)
Age 23 5.37 (2.31)
AUDIT-P score
(Mean, SD) C n/a
Sum of AUDIT items
4-10
Age 16 2.37 (3.18)
Age 18 2.48 (2.97)
Age 19 2.38 (2.89)
Age 21 3.16 (3.66)
Age 23 2.30 (2.93)  
n/a n/a
DSM alcohol
dependence
symptom
count
(Mean, SD)
C
Sum of 11 lifetime
criteria for
diagnosis of DSM-5
AUD
3.57 (3.68)
Sum of 7 criteria for
diagnosis of DSM-IV
AUD; maximum
observed across
waves
Age 18 0.35 (0.91)
Age 21 0.72 (1.30)
Age 23 0.43 (1.01)
n/a n/a
DSM-IV
alcohol
dependence
diagnosis
(N, %)
B
Clustering of ≥3 of
7 DSM-IV criteria
within 12 months
2,318 (33.8%)
Clustering of ≥3 of 7
DSM-IV criteria within
12 months at any
wave of assessment
(age 18, 21, or 23) 
484 (11.2%)
n/a n/a
ICD-9 and ICD-
10 alcohol
dependence
diagnosis (N,
%)
B n/a n/a n/a
ICD-9 code
of 303* or
ICD-10 code
of F10*
4,141
(1.68%)
CAGE scores
(Range 0-4;
Mean, SD)
C n/a n/a 0.603(0.93) n/a
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Table 2. Associations between AUDIT-C and AUDIT-P PRS and multiple indices of alcohol use in COGA, UKB, ALSPAC 
and GS samples. The PRS threshold (pT) that most strongly predicted each outcome (based on highest R2) is presented. Results 
significant at p < 0.0004 are bolded. Complete results are available in Supplemental Tables 1-12.
AUDIT-C PRS AUDIT-P PRS
Outcome Sample pT R2 Beta (SE) p-value pT R2 Beta (SE) p-value
Units per Week GS <0.1 0.27
%
0.052
(0.008)
5.50E-
11
<0.
01
0.15
%
0.039
(0.008)
4.70E-
07
Alcohol use COGA <0.000
1
0.32
%
0.129
(0.046)
5.19E-
03
<0.
4
0.65
%
0.188
(0.049)
1.24E-
04
AUDIT-C ALSPAC (age 23) <0.1 0.59
%
0.066
(0.020)
1.06E-
03
<0.
01
0.65
%
0.067
(0.020)
5.90E-
04
Max Drinks ALSPAC  <0.5 1.54
%
0.389
(0.173)
2.44E-
02
<0.
2
3.26
%
0.540
(0.171)
1.59E-
03
COGA  <
0.001
0.04
%
0.266
(0.147)
7.03E-
02
 <
0.2
0.47
%
0.879
(0.156)
2.00E-
08
CAGE GS <0.4 0.19
%
0.044
(0.010)
8.60E-
04
<0.
2
0.40
%
0.063
(0.010)
9.00E-
07
AUDIT-P ALSPAC (age 23) <0.2 0.28
%
0.045
(0.020)
2.61E-
02
<0.
01
1.12
%
0.088
(0.020)
9.05E-
06
Alcohol Dependence 
Symptom Count
ALSPAC (DSM-IV) <0.3 0.84
%
0.091
(0.022)
3.59E-
05
<0.
01
0.84
%
0.086
(0.021)
3.53E-
05
COGA (DSM-5)  < 0.1 0.08
%
0.103
(0.045)
2.30E-
02
 <
0.4
0.67
%
0.301
(0.046)
1.01E-
10
Alcohol Dependence ALSPAC (DSM-IV) <0.3 0.96
%
0.240
(0.052)
4.81E-
06
<0.
01
0.54
%
0.170
(0.050)
5.75E-
04
COGA  (DSM-IV) <0.000
1
0.14
%
0.078
(0.032)
1.44E-
02
<0.
4
0.68
%
0.199
(0.034)
4.55E-
09
UKB (ICD) <0.00
01
0.04
%
0.062
(0.016)
8.90E-
05
<0.
5
0.18
%
0.147
(0.020)
<
2.00E-
16
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FIGURE CAPTIONS
Figure 1. Odds Ratios (OR) and 95% confidence interval for alcohol 
dependence diagnosis by PRS quartiles in ALSPAC, COGA, and UKB. PRS 
were split into quartiles and odds ratios calculated for case status for each quartile 
of risk compared to quartile 1 (lowest). A. Alcohol dependence in ALSPAC was 
coded by DSM-IV diagnosis (484 cases, 3,837 controls).  B. Alcohol dependence was
coded via DSM-IV diagnosis in the COGA sample (2,318 cases, 4,532 controls). C. A 
sample of European ancestry, unrelated British individuals who had ever drank, had 
ICD9 and ICD-10 codes available, and were not included in the discovery GWAS 
were used (4,141 cases, 241,806 controls).
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Figure 2. Overview of the magnitude of predicted variance (R2, %) across 
the alcohol-related phenotypes probed in the four independent samples 
(Generation Scotland, GS; ALSPAC at age 23, A23; Collaborative Study on 
the Genetics of Alcoholism, COGA; and UK Biobank, UKB). The color of the 
dots denotes AUDIT-C (light gray) or AUDIT-P (dark gray) PRS. Only the significant (p
< 0.0004) associations are shown. C, AUDIT-C; P, AUDIT-P.
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